EU-funded projects dealing with key enabling biotechnologies face a common challenge: Time-to-market of their results is often too long. There are several key reasons for this including: lack of commercialization knowledge, contacts and exploitation pathways. Within the KETBIO projects, these hurdles were analysed more closely and material was developed to support reserachers and prospective entrepreneurs in fields such as communications, attracting investors, handling IP or finding new funding. In the recording Biotech Commercialisation in a Nutshell, the KETBIO Consortia presents its findings in a comprehensive one-hour webinar. More resources are available on different topics - check the "Library" to find more.